title: Fat reduction using phosphatidylcholine/sodium deoxycholate injections: standard of practice.
abstract: The practice of injecting phosphatidylcholine/sodium deoxycholate compounds into subcutaneous fat is growing rapidly. As with any new procedure, a standard of practice should be developed so that practitioners maintain patient safety as the primary goal. Efficacy and predictability of outcome are another priority. As injection lipolysis, also known as "lipodissolve," becomes more accepted, many standards are being set, such as indications, contraindications, acceptable postinjection sequelae, best regions to treat, regions to avoid, and expected outcomes. This article establishes a basis of practice for the practitioner interested in adding this procedure to his or her repertoire.
authors.affiliation: Duncan@aol.com
authors.forename: Diane Irvine
authors.initials: DI
authors.lastname: Duncan
authors.forename: Mark
authors.initials: M
authors.lastname: Palmer
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects*; D000328:Adult; D003357:Cosmetic Techniques / Q000592:standards; D003840:Deoxycholic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004954:Esthetics; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D015187:Lipectomy / Q000379:methods* / Q000592:standards; D008875:Middle Aged; D017060:Patient Satisfaction; D018579:Patient Selection; D010713:Phosphatidylcholines / Q000008:administration & dosage* / Q000009:adverse effects; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D010713:Phosphatidylcholines; D003840:Deoxycholic Acid